To amend the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to require health insurance coverage of drugs indicated for the treatment of autoimmune diseases and certain blood disorders.

6/9/2026, 8:06 AM

Summary of Bill HR 9192

The bill titled "To amend the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to require health insurance coverage of drugs indicated for the treatment of autoimmune diseases and certain blood disorders," designated as H.R. 9192 in the 119th Congress and introduced on June 8, 2026, aims to mandate health insurance coverage for drugs used in treating autoimmune diseases and specific blood disorders.

Current Status of Bill HR 9192

Bill HR 9192 is currently in the status of Bill Introduced since June 8, 2026. Bill HR 9192 was introduced during Congress 119 and was introduced to the House on June 8, 2026. Bill HR 9192's most recent activity was Referred to the Committee on Energy and Commerce, and in addition to the Committees on Education and Workforce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned. as of June 8, 2026

Bipartisan Support of Bill HR 9192

Total Number of Sponsors

Democrat Sponsors

Republican Sponsors

Unaffiliated Sponsors

Total Number of Cosponsors

Democrat Cosponsors

Republican Cosponsors

Unaffiliated Cosponsors

Policy Area and Potential Impact of Bill HR 9192

Primary Policy Focus

Alternate Title(s) of Bill HR 9192

To amend the Employee Retirement Income Security Act of 1974, title XXVII of the Public Health Service Act, and the Internal Revenue Code of 1986 to require health insurance coverage of drugs indicated for the treatment of autoimmune diseases and certain blood disorders.